MNK-6105
- Generic Name
- MNK-6105
MNK-6105 for Patients With Cirrhosis and High Ammonia Levels Affecting Brain Function
Phase 3
Withdrawn
- Conditions
- Hepatic Encephalopathy
- Interventions
- First Posted Date
- 2019-10-16
- Last Posted Date
- 2021-09-22
- Lead Sponsor
- Mallinckrodt
- Registration Number
- NCT04128462
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath